MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven

Jolien De Wyn1, Mark W Zimmerman2, Nina Weichert-Leahey2

  • 1Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.

Cancers
|October 13, 2021
PubMed

Insights

Researchers identified key factors like MEIS2 and ASCL1 driving neuroblastoma formation in MYCN-amplified tumors. This study reveals novel therapeutic targets for this aggressive pediatric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MYCN amplification is present in about half of high-risk neuroblastoma patients.
  • The early steps of MYCN-driven neuroblastoma initiation remain poorly understood.
  • Understanding these early events is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the molecular landscape of early neuroblastoma development in a MYCN-driven model.
  • To identify novel factors involved in tumor initiation and maintenance.
  • To discover potential therapeutic targets for MYCN-driven neuroblastoma.

Main Methods:

  • Performed time-resolved transcriptome analysis in a murine TH-MYCN neuroblastoma model.
  • Utilized bioinformatics to identify candidate tumor-initiating factors and regulatory circuits.
  • Conducted cross-species master regulator analysis to identify key transcriptional hubs.

Main Results:

  • Identified MEIS2 and ASCL1 as potential tumor-initiating factors in adrenergic neuroblastomas.
  • Found upregulation of KEOPS complex member (gm6890), Claspin (CLSPN), and chromosome 17q loci (CBX2, GJC1, LIMD2) during tumor formation.
  • FOXM1 identified as a master regulator controlling transcriptome profiles in MYCN-driven neuroblastoma.

Conclusions:

  • Time-resolved transcriptome analysis revealed novel components in early neuroblastoma lesions and established tumors.
  • These findings implicate new factors in both the initiation and maintenance of MYCN-driven neuroblastoma.
  • Identified putative novel drug targets for therapeutic intervention in MYCN-driven neuroblastoma.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.3K